{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:03:40Z","timestamp":1794441820996,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["214844"],"award-info":[{"award-number":["214844"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.biopha.2024.116177","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:19:25Z","timestamp":1705969165000},"page":"116177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro study"],"prefix":"10.1016","volume":"171","author":[{"given":"Sabrina","family":"Kuoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1617-6524","authenticated-orcid":false,"given":"Regula","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanja","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ochsenbein-K\u00f6lble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4489-0952","authenticated-orcid":false,"given":"Ana Paula","family":"Sim\u00f5es-W\u00fcst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116177_bib1","unstructured":"International Diabetes Federation, IDF Diabetes Atlas 10th Edition. 2021."},{"issue":"19","key":"10.1016\/j.biopha.2024.116177_bib2","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.biopha.2024.116177_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11892-019-1267-6","article-title":"Hyperglycemia during pregnancy and long-term offspring outcomes","volume":"19","author":"Bianco","year":"2019","journal-title":"Curr. Diab Rep."},{"issue":"12","key":"10.1016\/j.biopha.2024.116177_bib4","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2337\/diabetes.49.12.2208","article-title":"Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships","volume":"49","author":"Dabelea","year":"2000","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2024.116177_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.diabres.2012.09.002","article-title":"Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment","volume":"98","author":"Falavigna","year":"2012","journal-title":"Diabetes Res Clin. Pract."},{"key":"10.1016\/j.biopha.2024.116177_bib6","doi-asserted-by":"crossref","unstructured":"U. Sch\u00e4fer-Graf, et al., Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. Der Diabetologe 16(S 02) (2022) 215-225.","DOI":"10.1055\/a-1581-6175"},{"key":"10.1016\/j.biopha.2024.116177_bib7","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee, et al., 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. Diabetes Care, 2022. 45(Suppl 1): p. 125\u2013143.","DOI":"10.2337\/dc22-S009"},{"key":"10.1016\/j.biopha.2024.116177_bib8","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee, et al., 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care, 2022. 45(Suppl 1): p. 232\u2013243.","DOI":"10.2337\/dc22-S015"},{"issue":"16","key":"10.1016\/j.biopha.2024.116177_bib9","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3390\/ijerph16162965","article-title":"SGLT2 inhibitors: a review of their antidiabetic and cardioprotective effects","volume":"16","author":"Tentolouris","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.biopha.2024.116177_bib10","unstructured":"Janssen-Cilag. Invokana Product information. 16.01.2023."},{"key":"10.1016\/j.biopha.2024.116177_bib11","unstructured":"Boehringer Ingelheim. Jardiance Product information. 16.01.2023."},{"key":"10.1016\/j.biopha.2024.116177_bib12","unstructured":"AstraZeneca A.B. Forxiga Product information. 16.01.2023."},{"key":"10.1016\/j.biopha.2024.116177_bib13","first-page":"50401","article-title":"Determination of the transport rate of xenobiotics and nanomaterials across the placenta using the ex vivo human placental perfusion model","volume":"76","author":"Grafmuller","year":"2013","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.biopha.2024.116177_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clin. Pharm. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116177_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.taap.2015.09.007","article-title":"Prenatal caffeine exposure induced a lower level of fetal blood leptin mainly via placental mechanism","volume":"289","author":"Wu","year":"2015","journal-title":"Toxicol. Appl. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116177_bib16","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1038\/s41598-017-06364-z","article-title":"A comparative study of five physiological key parameters between four different human trophoblast-derived cell lines","volume":"7","author":"Rothbauer","year":"2017","journal-title":"Sci. Rep."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116177_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2005.05.003","article-title":"Directional secretion and transport of leptin and expression of leptin receptor isoforms in human placental BeWo cells","volume":"241","author":"Wyrwoll","year":"2005","journal-title":"Mol. Cell Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116177_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00410692","article-title":"Sodium butyrate stimulates hCG and hCG-alpha production in a human choriocarcinoma cell line (BeWo)","volume":"100","author":"Kinoshita","year":"1981","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.116177_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.160403","article-title":"Experimental human placental models for studying uptake, transport and toxicity of micro- and nanoplastics","volume":"860","author":"Dusza","year":"2023","journal-title":"Sci. Total Environ."},{"issue":"2","key":"10.1016\/j.biopha.2024.116177_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/a-1829-9546","article-title":"Placental passage of protopine in an ex vivo human perfusion system","volume":"89","author":"Spiess","year":"2022","journal-title":"Planta Med"},{"issue":"10","key":"10.1016\/j.biopha.2024.116177_bib21","doi-asserted-by":"crossref","DOI":"10.1289\/EHP4860","article-title":"Transfer and metabolism of the xenoestrogen zearalenone in human perfused placenta","volume":"127","author":"Warth","year":"2019","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"10.1016\/j.biopha.2024.116177_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-0897.1997.tb00513.x","article-title":"Protein transport across the in vitro perfused human placenta","volume":"38","author":"Malek","year":"1997","journal-title":"Am. J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116177_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/A:1016674503298","article-title":"Capacity for hormone production of cultured trophoblast cells obtained from placentae at term and in early pregnancy","volume":"18","author":"Malek","year":"2001","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.biopha.2024.116177_bib24","doi-asserted-by":"crossref","first-page":"1123194","DOI":"10.3389\/fphar.2023.1123194","article-title":"Transplacental passage of hyperforin, hypericin, and valerenic acid","volume":"14","author":"Spiess","year":"2023","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2024.116177_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123841","article-title":"Simultaneous LC-MS\/MS quantification of SGLT2 inhibitors and antipyrine in medium and tissue from human ex vivo placenta perfusions","volume":"1228","author":"Kuoni","year":"2023","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116177_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09513590500099305","article-title":"Progesterone and human placental lactogen inhibit leptin secretion on cultured trophoblast cells from human placentas at term","volume":"21","author":"Coya","year":"2005","journal-title":"Gynecol. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116177_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0002-9378(84)90186-8","article-title":"Effect of estradiol and progesterone on human chorionic gonadotropin secretion in vitro","volume":"149","author":"Wilson","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116177_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1095\/biolreprod.105.045120","article-title":"Leptin in pregnancy: an update","volume":"74","author":"Henson","year":"2006","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.biopha.2024.116177_bib29","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/REP-17-0512","article-title":"Involvement of leptin in the molecular physiology of the placenta","volume":"155","author":"Schanton","year":"2018","journal-title":"Reproduction"},{"issue":"9","key":"10.1016\/j.biopha.2024.116177_bib30","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3390\/jcm11092433","article-title":"Significance of serum-plasma leptin profile during pregnancy in gestational diabetes mellitus: a systematic review and meta-analysis","volume":"11","author":"Roca-Rodr\u00edguez","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2024.116177_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jchemneu.2014.05.001","article-title":"The impact of leptin on perinatal development and psychopathology","volume":"61-62","author":"Valleau","year":"2014","journal-title":"J. Chem. Neuroanat."},{"issue":"8","key":"10.1016\/j.biopha.2024.116177_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/a-0958-2441","article-title":"Systematic review and meta-analysis of randomized controlled trials on the effect of SGLT2 inhibitor on blood leptin and adiponectin level in patients with type 2 diabetes","volume":"51","author":"Wu","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.biopha.2024.116177_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.placenta.2021.09.011","article-title":"The road (not) taken - placental transfer and interspecies differences","volume":"115","author":"Schmidt","year":"2021","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.biopha.2024.116177_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2015.04.015","article-title":"Pharmacokinetics, pharmacodynamics, and safety of single-dose canagliflozin in healthy Chinese subjects","volume":"37","author":"Chen","year":"2015","journal-title":"Clin. Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:37:17Z","timestamp":1792096637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"alternative-id":["S0753332224000581"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116177","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116177"}}